Neuromuscular Blocking Drugs: Discovery and Development

The era of relaxant anaesthesia [Editorial]. Br J Anaesth 1992; 69: 551–3

Sykes K. Harold Griffith Memorial Lecture. The Griffith legacy. Can J Anaesth 1993; 40: 351–74

Crul JA. Relaxant drugs: from native drugs to the selective agents of today. Acta Anaesthiol Scand 1982; 26: 406–15

McIntyre AR. Curare Its History, Nature, and Clinical Use. Chicago: University of Chicago Press, 1947: 1

Birmingham AT. Waterton and Wouralia. Br J Pharmacol 1999; 126: 1685–9

Brodie BC. Further experiments and observations on the action of poisons on the animal system. Phil Trans R Soc Lond 1812; 102: 205–27

Smith WDA. Waterton and Wouralia. Br J Anaesth 1983; 55: 221–5

Bynum WF. Chemical structure and pharmacological action: a chapter in the history of 19th century molecular pharmacology. Bull Hist Med 1970; 44: 518–38

Dale HH. Chemical transmission of the effects of nerve impulses. BMJ 1934; i: 835–41

King H. Curare alkaloids: 1, tubocurarine. J Chem Soc 1935: 1381–89

Humble RM. The Gill–Merrill Expedition. Penultimate chapter in the curare story. Anesthesiology 1982; 57: 5159–26

Wintersteiner O. , Dutcher JD. Curare alkaloids from Chondrodendron tomentosum. Science 1943; 97: 467–70

Bennett AE. Curare: a preventive of traumatic complication in convulsive shock therapy. Am J Psychiatry 1994; 151(suppl): 249–58

Betcher AM. The civilizing of curare. Anesth Analg (Curr Res) 1977; 56: 305–19

Gillies D. , Wynands JE. Harold Randall Griffith, MD, CM, the pioneer of the use of muscle relaxants in anaesthesia. Br J Anaesth 1986; 58: 943–5

Griffith H.R. , Johnson GE. The use of curare in general anaesthesia. Anesthesiology 1942; 3: 418–20

Kyle R.A. , Shampo MA. Harold R Griffith—introduction of muscle relaxants to anaesthesia. Mayo Clin Proc 1992; 67: 237

Gray TC. Luck was a lady. In: Atkinson R.S. , Boulton R.B. , eds. The History of Anaesthesia. London: Royal Society of Medicine Press, 1989: 16–19

Gray T.C. , Halton J. A milestone in anaesthesia? (d-tubocurarine chloride). Proc R Soc Med 1946; 39: 400–10

Ing HR. The curariform activity of onium salts. Physiol Rev 1936; 16: 527–44

Barlow R.B. , Ing HR. Curare-like action of polymethylene bisquaternary ammonium salts. Br J Pharmacol 1948; 3: 289–304

Paton W.D.M. , Zaimis EJ. The pharmacological actions of polymethylene bistrimethyl ammonium salts. Br J Pharmacol 1949; 4: 381–400

Dorkins HR. Suxamethonium—the development of a modern drug from 1906 to the present day. Med Hist 1982; 26: 145–68

Burns B.D. , Paton WDM. Depolarisation of the motor end plate by decamethonium and acetylcholine. J Physiol 1951; 115: 41–73

Baird W.L.M. , Reid AM. The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man. Br J Anaesth 1967; 39: 775–80

Savarese J.J. , Kitz RJ. Does clinical anaesthesia need new neuromuscular blocking agents? Anesthesiology 1975; 42: 236–9

Buckett W.R. , Hewett C.L. , Savage DS. Pancuronium bromide and other neuromuscular blocking agents containing acetylcholine fragments. J Med Chem 1973; 16: 1116–24

Stenlake J.B. , Waigh R.D. , Urwin J. , Dewar G.H. , Coker GG. Atracurium: conception and inception. Br J Anaesth 1983; 55: 3S–10S

Stenlake J.B. , Waigh R.D. , Dewar GH. Biodegradable neuromuscular blocking agents. Part 4 Atracurium besylate and related polyalkylene di-esters. Eur J Med Chem 1981; 16: 515–24

Savarese J.J. , Miller R.D. , Lein C.A. , Caldwell JE. Phamacology of muscle relaxants and their antagonists. In: Miller RD, ed. Anesthesia, 4th edn. New York: Churchill Livingstone, 1994: 417

Bowman W.C. , Rodger I.W. , Houston J. , Marshall R.J. , McIndewar I. Structure: action relationships among some desacetoxy analogs of pancuronium and vecuronium in the anaesthetised cat. Anesthesiology 1988; 69: 57–62

Rapacuronium (Org 9487): do we have a replacement for succinylcholine? [Editorial]. Br J Anaesth 1999; 82: 489